Issue Date: December 5, 2016
Drug firm may have used tainted heparin
FDA has issued a warning to the Chinese drug ingredient manufacturer Dongying Tiandong Pharmaceuticals for failing to investigate results that showed some of its heparin may have been extracted from animals other than pigs. Shandong-based Dongying tested batches that showed its heparin may have been extracted from cattle, goats, sheep or other ruminants but didn’t investigate suppliers, FDA found. North American and European countries currently allow heparin only from pig sources. Heparin from sheep or . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society